🇺🇸 FDA

Intelligence · Patent portfolio

Teva Pharma Patents

Full USPTO pharma patent portfolio for Teva Pharma — grant dates, expiration, and drug cross-links.

Patents
454
Expiring ≤24m
49

Quick answer

Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months — use filters for patent-cliff planning.

Page 10 of 10

  1. US 6500987

    Sertraline hydrochloride polymorphs

    Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6495721

    Sertraline hydrochloride Form II and methods for the preparation thereof

    Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6492426

    Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

    Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6482417

    Stable pharmaceutical formulation comprising torsemide modification II

    Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6476006

    Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

    Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6465496

    Torsemide polymorphs

    Expires Mon Oct 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6462222

    Aminoindan derivatives

    Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6452054

    Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

    Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6376545

    Dispersible compositions containing L-DOPA ethyl ester

    Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6365574

    Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

    Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6316504

    Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

    Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6306436

    Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

    Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6303650

    Aminoindan derivatives

    Expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6281381

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6277886

    Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan

    Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6271263

    Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

    Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6248888

    Process for the preparation of terazosin hydrochloride dihydrate

    Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6218566

    Process for manufacturing of L-DOPA ethyl ester

    Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6201148

    Process for preparing alendronic acid

    Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6126968

    Stable compositions containing N-propargyl-1-aminoindan

    Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6127426

    10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals

    Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6017531

    Hydrophilic composition containing protease produced by Vibrio

    Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Teva Pharma have?

454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.